Literature DB >> 31678321

The lytic bacteriophage vB_EfaH_EF1TV, a new member of the Herelleviridae family, disrupts biofilm produced by Enterococcus faecalis clinical strains.

Marco Maria D'Andrea1, Domenico Frezza2, Elena Romano2, Pasquale Marmo2, Lucia Henrici De Angelis3, Nicoletta Perini2, Maria Cristina Thaller2, Gustavo Di Lallo4.   

Abstract

OBJECTIVES: The aim of this study is to characterize a new bacteriophage able to infect Enterococcus faecalis, and to evaluate its ability to disrupt biofilm.
METHODS: The vB_EfaH_EF1TV (EF1TV) host-range was determined by spot test and efficiency of plating using a collection of 15E. faecalis clinical strains. The phage genome was sequenced with a next generation sequencing approach. Anti-biofilm activity was tested by crystal violet method and confocal laser scanning microscopy. Phage-resistant mutants were selected and sequenced to investigate receptors exploited by phage for infection.
RESULTS: EF1TV is a newly discoveredE. faecalis phage which belongs to the Herelleviridae family. EF1TV, whose genome is 98% identical to φEF24C, is characterized by a linear dsDNA genome of 143,507 bp with direct terminal repeats of 1,911 bp. The phage is able to infect E. faecalis and shows also the ability to degrade biofilm produced by strains of this species. The results were confirmed by confocal laser scanning microscopy analyzing the biofilm reduction in the same optical field before and after phage infection.
CONCLUSIONS: The EF1TV phage shows promising features such as an obligatory lytic nature, an anti-biofilm activity and the absence of integration-related proteins, antibiotic resistance determinants and virulence factors, and therefore could be a promising tool for therapeutic applications.
Copyright © 2019 International Society for Antimicrobial Chemotherapy. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Herelleviridae family; Phage therapy; SPO1-like phage; bacteriophage resistance; biofilm degradation

Mesh:

Year:  2019        PMID: 31678321     DOI: 10.1016/j.jgar.2019.10.019

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  5 in total

Review 1.  Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era.

Authors:  Chih-Hung Wang; Yi-Hsien Hsieh; Zachary M Powers; Cheng-Yen Kao
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

Review 2.  Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance.

Authors:  Cristina Uruén; Gema Chopo-Escuin; Jan Tommassen; Raúl C Mainar-Jaime; Jesús Arenas
Journal:  Antibiotics (Basel)       Date:  2020-12-23

3.  Impact of a phage cocktail targeting Escherichia coli and Enterococcus faecalis as members of a gut bacterial consortium in vitro and in vivo.

Authors:  Colin Buttimer; Tom Sutton; Joan Colom; Ellen Murray; Pedro H Bettio; Linda Smith; Andrei S Bolocan; Andrey Shkoporov; Akihiko Oka; Bo Liu; Jeremy W Herzog; R Balfour Sartor; Lorraine A Draper; R Paul Ross; Colin Hill
Journal:  Front Microbiol       Date:  2022-07-22       Impact factor: 6.064

4.  Anti-biofilm Activity of a Lytic Phage Against Vancomycin-Resistant Enterococcus faecalis.

Authors:  Forough Goodarzi; Masoumeh Hallajzadeh; Mohammad Sholeh; Malihe Talebi; Vahid Pirhajati Mahabadi; Nour Amirmozafari
Journal:  Iran J Pathol       Date:  2022-08-12

Review 5.  Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review.

Authors:  Zahra Chegini; Amin Khoshbayan; Majid Taati Moghadam; Iman Farahani; Parham Jazireian; Aref Shariati
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-09-30       Impact factor: 3.944

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.